secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADC Therapeutics SA (ADCT)
CIK:        0001771910
Form:       8-K
Filed at:   2024-11-13T23:59:59+00:00
Accession:  0000950103-24-016242
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADC Therapeutics shareholders approve capital range increase and conditional share capital amendments
--------------------------------------------------------------------------------

- Shareholders approved amendment to Article 4a to increase capital range (52.4M for, 9.0M against).
- Shareholders approved amendment to Article 4c to increase conditional share capital for financing/acquisitions (52.3M for, 9.0M against).
- Amendments to articles of association became effective immediately upon approval at Nov 11, 2024 special meeting.
- Broker non-votes: none reported for either proposal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1771910/000095010324016242/0000950103-24-016242-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1771910/000095010324016242/dp220630_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-24-016242

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer